ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,605, issued on Dec. 16, was assigned to Crosswalk Therapeutics Inc. (Cambridge, Mass.).
"Engineered acid alpha-glucosidase variants" was invented by William Casey Hallows (San Francisco), Rachel Cathleen Botham (Burlingame, Calif.), Yu Zhu (Newark, Calif.), Chinping Chng (Menlo Park, Calif.), Nikki Dellas (San Carlos, Calif.), Gjalt W. Huisman (Redwood City, Calif.), Moulay Hicham Alaoui Ismaili (San Mateo, Calif.), David William Homan (San Ramon, Calif.), Adam P. Silverman (San Carlos, Calif.), Jonathan Vroom (South San Francisco, Calif.) and Jessica P. Lao (San Carlos, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pro...